New Key Statistics Module, Z-Score and F-Score
NAS:RKDA Key Ratios
| Market Cap $ M | 2.85 |
| Enterprise Value $ M | -7.79 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.21 |
| Price/Sales | 0.44 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5.00 |
| EPS (TTM) $ | -14.13 |
| Beneish M-Score | -1.67 |
| 10-y EBITDA Growth Rate % | 29.60 |
| 5-y EBITDA Growth Rate % | 40.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.54 |
| EV-to-EBITDA | 0.55 |
| PEG | -- |
| Shares Outstanding M | 1.36 |
| Net Margin (%) | -246.80 |
| Operating Margin % | -253.72 |
| Pre-tax Margin (%) | -241.22 |
| Quick Ratio | 3.63 |
| Current Ratio | 4.17 |
| ROA % (ttm) | -54.06 |
| ROE % (ttm) | -83.12 |
| ROIC % (ttm) | -272.02 |
| Dividend Yield % | -- |
| Altman Z-Score | -20.38 |
RKDA Number of Guru Trades
RKDA Volume of Guru Trades
Gurus Latest Trades with NAS:RKDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RKDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arcadia Biosciences Inc Insider Transactions
No Available Data
News about NAS:RKDA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers